urethral cancer

Showing 1 - 25 of 37

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Urologic Cancer, Urologic Tumors, Bladder Cancer Trial in Boston (Electromagnetic Guided Laparoscopy, Ultrasound)

Not yet recruiting
  • Urologic Cancer
  • +7 more
  • Electromagnetic Guided Laparoscopy
  • Ultrasound
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jun 8, 2023

Prostate Cancer, Renal Cancer, Urethral Cancer Trial in San Francisco (Copper-64 labeled Granzyme B (64Cu-GRIP B), Positron

Not yet recruiting
  • Prostate Cancer
  • +2 more
  • Copper-64 labeled Granzyme B (64Cu-GRIP B)
  • Positron Emission Tomography (PET)
  • San Francisco, California
    University of California, San Francisco
Jun 7, 2023

Primary and Metastatic Tumors in Renal Cell Carcinoma and

Recruiting
  • Renal Cell Carcinoma
  • +4 more
  • Immune checkpoint inhibitor targeting PD1
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center - Philadelphia
Jan 27, 2023

Solid Tumor, Urethral Cancer Trial in Houston (Bortezomib, Gemcitabine, Doxorubicin)

Active, not recruiting
  • Solid Tumor
  • Urethral Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 22, 2022

Melanoma, Breast Cancer, Uterine Cancer Trial in London (MRx0518 Capsules, MRx0518/ Capsules)

Active, not recruiting
  • Melanoma
  • +9 more
  • MRx0518 Capsules
  • MRx0518/placebo Capsules
  • London, United Kingdom
    Imperial College Healthcare NHS Trust
Aug 10, 2022

Pancreatic Cancer, Thyroid Cancer, Lung Cancer Trial in United States

Recruiting
  • Pancreatic Cancer
  • +49 more
    • Colorado Springs, Colorado
    • +80 more
    Feb 22, 2022

    Urothelial Carcinoma, Bladder Cancer, Urethral Cancer Trial in United States (Biospecimen Collection)

    Active, not recruiting
    • Urothelial Carcinoma
    • +3 more
    • Biospecimen Collection
    • Los Angeles, California
    • +7 more
    Feb 14, 2022

    Bladder Cancer, Urethral Cancer, Urachal Cancer Trial in Houston (5-Fluorouracil (5-FU), Leucovorin, Cisplatin)

    Active, not recruiting
    • Bladder Cancer
    • +2 more
    • 5-Fluorouracil (5-FU)
    • +3 more
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    May 18, 2021

    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Ureter Cancer Trial in United Kingdom (carboplatin,

    Completed
    • Bladder Cancer
    • +3 more
    • Glasgow, Scotland, United Kingdom
    • +20 more
    May 14, 2019

    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer Trial in United States (gemcitabine

    Completed
    • Bladder Cancer
    • +2 more
    • Cedar Rapids, Iowa
    • +15 more
    Dec 30, 2018

    Bladder Cancer, Urethral Cancer Trial in United States (carboplatin, cisplatin, doxorubicin HCl)

    Completed
    • Bladder Cancer
    • Urethral Cancer
    • Decatur, Georgia
    • +12 more
    Dec 30, 2018

    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer Trial in United Kingdom (cisplatin,

    Completed
    • Bladder Cancer
    • +2 more
    • Bristol, Avon, United Kingdom
    • +15 more
    Oct 25, 2018

    Kidney Cancer or Cancer of Urothelium and in Healthy

    Completed
    • Bladder Cancer
    • +3 more
    • immunologic technique
    • +2 more
    • Winston-Salem, North Carolina
      Wake Forest University Comprehensive Cancer Center
    Jul 3, 2018

    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer Trial in Leeds (cisplatin, gemcitabine

    Completed
    • Bladder Cancer
    • +2 more
    • Leeds, England, United Kingdom
      Leeds Cancer Centre at St. James's University Hospital
    Feb 2, 2018

    Bladder Cancer, Ureter Cancer, Urethral Cancer Trial in Korea, Republic of (Treatment duration of cisplatin based chemo)

    Unknown status
    • Bladder Cancer
    • +3 more
    • Treatment duration of cisplatin based chemotherapy
    • Yangsan, Gyeongsangnam-do, Korea, Republic of
    • +18 more
    Sep 23, 2017

    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer Trial in United States (gemcitabine

    Terminated
    • Bladder Cancer
    • +2 more
    • Mobile, Alabama
    • +91 more
    Jul 8, 2016

    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer Trial in New York (sunitinib malate)

    Completed
    • Bladder Cancer
    • +2 more
    • sunitinib malate
    • New York, New York
      Memorial Sloan-Kettering Cancer Center
    Dec 17, 2015

    Bladder Cancer, Urethral Cancer Trial in Houston (Recombinant Interferon Alfa)

    Completed
    • Bladder Cancer
    • Urethral Cancer
    • Recombinant Interferon Alfa
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    May 12, 2015

    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer Trial in Worldwide (fluorouracil)

    Completed
    • Bladder Cancer
    • +2 more
    • Porto Alegre, Rio Grande do Sul, Brazil
    • +61 more
    Dec 3, 2013

    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer Trial in Milan (pazopanib HCl,

    Completed
    • Bladder Cancer
    • +2 more
    • pazopanib hydrochloride
    • fludeoxyglucose F 18
    • Milan, Italy
      Fondazione Istituto Nazionale dei Tumori
    Aug 9, 2013

    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer Trial in Barcelona, Madrid (drug,

    Unknown status
    • Bladder Cancer
    • +2 more
    • sunitinib malate
    • +4 more
    • Barcelona, Spain
    • +3 more
    Aug 6, 2013

    Bladder Cancer, Urethral Cancer Trial in New York (cisplatin, ifosfamide, paclitaxel)

    Completed
    • Bladder Cancer
    • Urethral Cancer
    • New York, New York
      Memorial Sloan-Kettering Cancer Center
    Jul 2, 2013